Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / IPHA - GT Biopharma: Shift In Therapy Strategy Reduces Attractiveness

IPHA - GT Biopharma: Shift In Therapy Strategy Reduces Attractiveness

Innate Pharma S.A.
  • GT Biopharma is an early-stage oncology company with one clinical asset.
  • GT Biopharma will likely shift focus to their 2nd generation therapies, which are still preclinical.
  • Lack of meaningful positive catalysts in the next year reduces attractiveness of investment.

For further details see:

GT Biopharma: Shift In Therapy Strategy Reduces Attractiveness
Stock Information
Company Name: Innate Pharma S.A.
Stock Symbol: IPHA
Market: NYSE
Website: innate-pharma.com
Menu
IPHA IPHA Quote IPHA Short IPHA News IPHA Articles IPHA Message Board
Get IPHA Alerts

News, Short Squeeze, Breakout and More Instantly...